Literature DB >> 14340930

MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

R LAVERTY, D F SHARMAN.   

Abstract

Entities:  

Keywords:  ATROPINE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CATS; CAUDATE NUCLEUS; CEREBRAL CORTEX; CHLORPROMAZINE; CHROMATOGRAPHY; DEXTRO AMPHETAMINE; DOGS; DOPA; DOPAMINE; EPHEDRINE; EXPERIMENTAL LAB STUDY; FLUOROMETRY; GUANETHIDINE; MORPHINE; NOREPINEPHRINE; PARASYMPATHOLYTICS; PARKINSONISM; PHARMACOLOGY; PHENOBARBITAL; PROTEIN METABOLISM; RABBITS; RADIOMETRY; RESERPINE; SEROTONIN; THALAMUS; THIORIDAZINE; TRIFLUOPERAZINE; TRITIUM

Mesh：

Substances：

Year:  1965        PMID： 14340930      PMCID： PMC1704029          DOI： 10.1111/j.1476-5381.1965.tb01632.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  19 in total

1.  THE ORGANIZATION OF CORTICO-STRIATE CONNEXIONSIN THE RABBIT.

Authors:  J B CARMAN; W M COWAN; T P POWELL
Journal:  Brain       Date:  1963-09       Impact factor: 13.501

2.  Neuroleptics and extrapyramidal reactions in psychiatric patients.

Authors:  F J AYD
Journal:  Rev Can Biol       Date:  1961-06

3.  Some biochemical aspects of extrapyramidal diseases.

Authors:  A BARBEAU; T L SOURKES
Journal:  Rev Can Biol       Date:  1961-06

4.  The identification of an active metabolite of tremorine.

Authors:  A K CHO; W L HASLETT; D J JENDEN
Journal:  Biochem Biophys Res Commun       Date:  1961-07-26       Impact factor: 3.575

5.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

6.  Brain levels of 5-hydroxytryptamine after various agents.

Authors:  M K PAASONEN; N J GIARMAN
Journal:  Arch Int Pharmacodyn Ther       Date:  1958-03-01

7.  Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action.

Authors:  B A BRODIE; P A SHORE; A PLETSCHER
Journal:  Science       Date:  1956-06-01       Impact factor: 47.728

8.  The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs.

Authors:  M VOGT
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

9.  A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

Authors:  D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-02

10.  SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS.

Authors:  G B LESLIE; D R MAXWELL
Journal:  Br J Pharmacol Chemother       Date:  1964-04
View more
  48 in total

1.  Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

Authors:  B Scatton; C Garret; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 2.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

3.  BRL 20596, a novel anilide with central dopamine antagonist activity.

Authors:  W Campbell; M S Clark; P J Mitchell; P L Needham; J M Semple
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 4.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  The effect of morpine dependence on the vesicular content of adrenergic nerves in relation to arteriolar smooth muscle in the pancreas of the rat.

Authors:  J D Graham; J D Lever; T L Spriggs
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

6.  Morphine analgesia and the bulbospinal noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics.

Authors:  H Shiomi; H Takagi
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

7.  Turnover rate of brain 5-hydroxytryptamine increased by D-amphetamine.

Authors:  W D Reid
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

8.  Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.

Authors:  L D Fuenmayor; M Vogt
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

9.  The effect of tranquillizing drugs on the concentration of the sulphate ester of 4-hydroxy-3-methoxyphenylethane-1,2-diol in rat brain.

Authors:  T L Berridge; D F Sharman
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

10.  Tremor induced by tetrabenazine.

Authors:  D B Calne; R A Webster
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.